Gilead Announces Results from Study of Sovaldi(R) for Retreatment of Chronic Hepatitis C in Patients Not Cured with Prior Antiviral Therapy

Results Demonstrate Efficacy of Sovaldi-Based Regimen in GT1 Infected Patients Who Failed Prior Therapy with Other Direct Acting Antivirals Data Support Retreatment with Sovaldi-Based Regimen in GT2 or GT3 Infected Patients Who Failed Prior Treatment wi... BiopharmaceuticalsGilead Sciences, Sovaldi, sofosbuvir, hepatitis C
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news